Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

29 Aug 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to Hepatitis C virus research
Share to Liver Diseases and Immunity

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 22930597
DOI: 10.1136/annrheumdis-2012-202088

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infectionPMID 22930597Read ↗

Real-World Use of Rituximab in Rheumatoid Arthritis: A 3-Year Analysis from the RBSMR Biologic RegistrySemantic proximity Read ↗

Anakinra in the Management of Adult-Onset Still’s Disease: A Single-Center ExperienceSemantic proximity Read ↗

Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 TreatmentSemantic proximity Read ↗

Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registriesSemantic proximity Read ↗

Safety, Pharmacokinetics, Biomarker Response, and Efficacy of E6742, a Dual Antagonist of Toll-Like Receptors 7 and 8, in a First-in-Patient, Randomized, Double-Blind, Phase 1/2 Study in Systemic Lupus ErythematosusSemantic proximity Read ↗

Long-term effects of rituximab in rheumatoid arthritis: clinical, biologic, and pharmacogenetic aspects.Semantic proximity Read ↗

Effectiveness and Safety of Intravenous Golimumab With and Without Concomitant Methotrexate in Patients With Rheumatoid Arthritis in the Prospective, Noninterventional AWARE StudySemantic proximity Read ↗

A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic DiseasesSemantic proximity Read ↗

Long-term efficacy of adalimumab in hyperimmunoglobulin D and periodic fever syndrome.Semantic proximity Read ↗

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort studySemantic proximity Read ↗

Efficacy and safety of belimumab in immune thrombocytopenia secondary to systemic lupus erythematosusSemantic proximity Read ↗

Modern Pharmacologic Management of Rheumatoid Arthritis: From Methotrexate to Targeted TherapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.